Valiant Laboratories

Valiant Laboratories Days Payable Outstanding

The Days Payable Outstanding (DPO) of Valiant Laboratories (VALIANTLAB.NS) as of Nov 4, 2026 is 163.27. In the previous year, Days Payable Outstanding (DPO) was 127.46 — a change of 28.10% (higher).

Days Payable Outstanding

163.27

YoY

28.10%

Last updated:

Days Payable Outstanding (DPO) of Valiant Laboratories is 2026 163.27 . Days Payable Outstanding (DPO) of Valiant Laboratories was 2025 127.46 . It decreases by 28.10% higher compared to the previous year.

The Valiant Laboratories Days Payable Outstanding history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Days Payable Outstanding
Date
Days Payable Outstanding
Jan 1, 2021
36.19 INR
Jan 1, 2022
70.86 INR
Jan 1, 2023
60.63 INR
Jan 1, 2024
55.51 INR
Jan 1, 2025
127.46 INR
Jan 1, 2026
163.27 INR
The Valiant Laboratories Days Payable Outstanding history
YEARDays Payable OutstandingYoY
163.27+28.10%
127.46+129.61%
55.51-8.45%
60.63-14.43%
70.86+95.81%
36.19—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valiant Laboratories Stock analysis

What does Valiant Laboratories do? Valiant Laboratories Ltd manufactures paracetamol API/bulk drug for pharmaceutical applications, targeting medical conditions such as headache, muscle ache, arthritis, back ache, toothache, cold, and fever. The company operates a single manufacturing facility at Tarapur industrial estate, approximately 150 km from Nhava Sheva Port (JNPT), producing specialty chemicals and pharma intermediates for domestic and international markets. Its subsidiary, VALIANT ADVANCED SCIENCES PRIVATE LIMITED, supports the company's operations in the pharmaceutical sector. The firm's primary revenue comes from selling paracetamol API and specialty chemicals to pharmaceutical companies and distributors globally. Manufacturing focuses on high-demand applications like pain relief and fever treatment, with products distributed across India and abroad. The company leverages its Tarapur facility's proximity to Nhava Sheva Port for efficient export logistics. Valiant Laboratories Ltd serves the pharmaceutical industry by supplying essential active ingredients, particularly paracetamol, which is widely used in over-the-counter medications. The company's manufacturing capabilities for specialty chemicals and pharma intermediates cater to both domestic and international clients seeking reliable API sources. Its single-location production model ensures focused resource allocation for consistent output quality. Valiant Laboratories is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Valiant Laboratories stock

Days Payable Outstanding (DPO) of Valiant Laboratories is 163.27 in 2026.

Days Payable Outstanding (DPO) of Valiant Laboratories changed from 127.46 to 163.27, representing a 28.10% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Days Payable Outstanding (DPO) Valiant Laboratories since 2006 – with annual values, charts, and detailed analysis.

DPO measures the average number of days a company takes to pay its suppliers. Higher DPO can improve cash flow but may strain supplier relationships.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Days Payable Outstanding (DPO)'s Valiant Laboratories with sector peers and the industry average to assess whether it is attractive.

To evaluate Days Payable Outstanding (DPO)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Days Payable Outstanding (DPO).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Valiant Laboratories

All Key Metrics — Valiant Laboratories